U.S. Senate Confirms Dr. Marty Makary as FDA Commissioner
Yesterday, the U.S. Senate voted to confirm Dr. Marty Makary as the next commissioner of the Food and Drug Administration (FDA).
Yesterday, the U.S. Senate voted to confirm Dr. Marty Makary as the next commissioner of the Food and Drug Administration (FDA).
Yesterday, the U.S. Senate voted to confirm Jay Bhattacharya, MD, PhD, as the new director of the National Institutes of Health (NIH).
In a new, large national study published today in the Journal of the American Medical Association (JAMA) Network Open, American Cancer Society (ACS) researchers found the 2018 federal policy loosening restrictions on STLD insurance plans was associated with an increase in late-stage cancer diagnoses in states without or with inadequate additional STLD plan regulatory protections.
Today, the American Cancer Society Cancer Action Network (ACS CAN), along with partner organizations, filed an amicus curiae brief with the Supreme Court of the United States (SCOTUS) in the case of Medina v. Planned Parenthood.
Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds.
“With over 2 million people in America expected to be diagnosed with cancer in 2025, now is not the time to halt investments in cancer research, prevention and early detection programs.
This week, the U.S. House of Representatives is expected to consider a budget resolution that could lead to devastating cuts to Medicaid. Ahead of the vote, the American Cancer Society Cancer Action Network (ACS CAN) is urging House members to oppose cuts to Medicaid.
Washington, D.C. - Last night, the Solicitor General’s office filed its merits brief in the U.S. Supreme Court case of Braidwood Management v.
A broad coalition of patient organizations today issued the following statement in response to cuts in staff, and research funding at federal agencies vital for American health.